According to a new study, it seems that a worsening metabolic syndrome is linked to cancer. Here are the most important highlights of the reports below.
Cancer and metabolic syndrome links addressed
Individuals who have metabolic syndrome, a collection of conditions such as high blood pressure, high blood sugar, abnormal cholesterol, and excess abdominal fat, have a greater risk of developing specific types of cancer. These findings have been published in the journal Cancer, which is a peer-reviewed publication of the American Cancer Society.
Metabolic syndrome affects about one in three adults in the United States and other countries, according to the National Institutes of Health (NIH). The NIH notes that a person is likely to have metabolic syndrome if they have three or more of the following conditions:
A large waistline
High blood pressure
High blood sugar levels
High blood triglycerides
Low HDL cholesterol
Research has found that individuals with worsening metabolic syndrome are at a higher risk of developing various types of cancer.
According to the latest reports, it looks like they are 1.3 times more likely to develop any cancer, 2.1 times more likely to develop breast cancer, 3.3 times more likely to develop endometrial cancer, 4.5 times more likely to develop kidney cancer, 2.5 times more likely to develop colorectal cancer, and 1.6 times more likely to develop liver cancer than those without worsening metabolic syndrome patterns.
“To the best of our knowledge, this study represents the first comprehensive evaluation of the impact of heterogeneous MetS score trajectories on the risks of overall and site-specific cancers,” the research team notes in the interesting study.
Another important issue that has been revealed via the study states the following:
“This research suggests that proactive and continuous management of metabolic syndrome may serve as an essential strategy in preventing cancer,” Dr. Han-Ping Shi, lead author, said in a press release.
“Our study can guide future research into the biological mechanisms linking metabolic syndrome to cancer, potentially resulting in targeted treatments or preventive strategies. Formal evaluation of these interventions will be needed to determine if they are able to modulate cancer risk.”
